Novartis

Novartis enters into $265-million schizophrenia drug deal with Vanda

13 Oct 2009

Novartis acquires global marketing rights for new drug from Paratek

09 Oct 2009

Novartis moves Supreme Court on Glivec patent

29 Aug 2009

Novartis' patent aplication for cancer drug Glivec rejected

07 Jul 2009

Sandoz receives approval for first-ever Japanese biosimilar

25 Jun 2009

Novartis's open offer for Indian arm to begin on 14 May

27 Mar 2009

Novartis makes open offer for 39 per cent in Indian arm

25 Mar 2009

Swiss drug maker Novartis AG will acquire an additional 39 per cent in its Indian subsidiary Novartis India Ltd from the public for about Rs440 crore to raise its stake to 90 per cent.

Unicef, Novartis among Mudra's new acounts

09 Dec 2008

Novartis completes first step acquisition of 25-per cent stake in Alcon from Nestlé

08 Jul 2008

Dr Reddy's announces settlement of Exelon (rivastigmine tartrate ) ANDA litigation with Novartis

By Our Corporate Bureau | 21 Jan 2008

Novartis plans to cut 22,00 jobs worldwide

13 Dec 2007

US FDA declares Novartis painkiller Prexige is ''not approvable''

By | 28 Sep 2007

Chennai court rejects Novartis patent challenge

By | 06 Aug 2007

Nestle to acquire Gerber for $5.5 billion; eyes US expansion

12 Apr 2007

Novartis slumps after pulling Zelnorm

31 Mar 2007

Diovan receives EU approval for the treatment of heart attack survivors

By Our Corporate Bureau | 10 May 2005

Novartis launches development centre in Mumbai

By Our Corporate Bureau | 28 Apr 2004

Novartis acquires global rights for Torrent’s AGE compound

By Suneeta Kaul | 07 Nov 2002

Novartis sale of property to Kingston through

By Pradeep Rane | 09 Sep 2002

Novartis goes on with Dr Reddys work

By Praveen Chandran | 26 Dec 2001

Zelmac withdrawn over disagreements on clinical results

01 Jun 2001

Novartis to distribute cancer drug free to needy

11 May 2001